Cargando…
Erratum: Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152380/ https://www.ncbi.nlm.nih.gov/pubmed/34084113 http://dx.doi.org/10.4103/1658-631X.315143 |
Ejemplares similares
-
Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia
por: AlShehry, Nawal, et al.
Publicado: (2021) -
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study
por: Albalawi, Mohammed, et al.
Publicado: (2020) -
Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
por: Petersenn, Stephan, et al.
Publicado: (2013) -
Erratum: Prevalence and characterization of urolithiasis in the Western region of Saudi Arabia
Publicado: (2020) -
Erratum: Cataract Surgery Audit at a Private Hospital in Saudi Arabia
Publicado: (2016)